Shares of GSK, Sanofi and Haleon plunge more than 13% on the probability that the drug Zantac contains a carcinogen
The actions of GSK, Sanofi Y Haleon They fell sharply on Thursday morning, after dipping earlier in the week as concern grew over litigation in the United States over a heartburn drug